SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:uu-401403"
 

Sökning: onr:"swepub:oai:DiVA.org:uu-401403" > Fluoxetine for stro...

  • Mead, Gillian E. (författare)

Fluoxetine for stroke recovery : Meta-analysis of randomized controlled trials

  • Artikel/kapitelEngelska2020

Förlag, utgivningsår, omfång ...

  • 2019-10-17
  • SAGE Publications,2020
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-401403
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-401403URI
  • https://doi.org/10.1177/1747493019879655DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:142106110URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • OBJECTIVE: To determine whether fluoxetine, at any dose, given within the first year after stroke to patients who did not have to have mood disorders at randomization reduced disability, dependency, neurological deficits and fatigue; improved motor function, mood, and cognition at the end of treatment and follow-up, with the same number or fewer adverse effects.METHODS: Searches (from 2012) in July 2018 included databases, trials registers, reference lists, and contact with experts. Co-primary outcomes were dependence and disability. Dichotomous data were synthesized using risk ratios (RR) and continuous data using standardized mean differences (SMD). Quality was appraised using Cochrane risk of bias methods. Sensitivity analyses explored influence of study quality.RESULTS: The searches identified 3414 references of which 499 full texts were assessed for eligibility. Six new completed RCTs (n = 3710) were eligible, and were added to the seven trials identified in a 2012 Cochrane review (total: 13 trials, n = 4145). There was no difference in the proportion independent (3 trials, n = 3249, 36.6% fluoxetine vs. 36.7% control; RR 1.00, 95% confidence interval 0.91 to 1.09, p = 0.99, I2 = 78%) nor in disability (7 trials n = 3404, SMD 0.05, -0.02 to 0.12 p = 0.15, I2 = 81%) at end of treatment. Fluoxetine was associated with better neurological scores and less depression. Among the four (n = 3283) high-quality RCTs, the only difference between groups was lower depression scores with fluoxetine.CONCLUSION: This class I evidence demonstrates that fluoxetine does not reduce disability and dependency after stroke but improves depression.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Legg, Lynn (författare)
  • Tilney, Russel (författare)
  • Hsieh, Cheng Fang (författare)
  • Wu, Simiao (författare)
  • Lundström, Erik,1964-Karolinska Institutet,Uppsala universitet,Landtblom: Neurovetenskap,Department of Clinical Neuroscience, Karolinska Institutet(Swepub:uu)erlun676 (författare)
  • Rudberg, Ann SofieKarolinska Institutet (författare)
  • Kutlubaev, Mansur (författare)
  • Dennis, Martin S. (författare)
  • Soleimani, Babak (författare)
  • Barugh, Amanda (författare)
  • Hackett, Maree L. (författare)
  • Hankey, Graeme J. (författare)
  • Uppsala universitetLandtblom: Neurovetenskap (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:International Journal of Stroke: SAGE Publications15:4, s. 365-3761747-49301747-4949

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy